Sign in

CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(310) 358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
  1. 4 Option exercise CHIEF FINANCIAL OFFICER acquired 2,178 shares (option exercise)
  2. 4 Open-market buy Director bought 410 shares at $2.75 ($1,128)
  3. 4 Open-market buy Director bought 10,000 shares at $2.83 ($28,300)
  4. 4 Open-market buy Director bought 5,083 shares at $2.82 ($14,334)
  5. 4 Open-market buy Director bought 5,000 shares at $2.84 ($14,200)
  6. 4 Open-market buy Director bought 2,500 shares at $2.90 ($7,250)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Shares withheld for taxes Director gave up 4,364 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 20,749 shares (option exercise)
  15. 4 Open-market sale Former CBO sold 14,772 shares at $64,258.00 ($949,219,176)
  16. 4 Open-market sale FORMER CHIEF BUSINESS OFFICER sold 3,000 shares at $4.06 ($12,180)
  17. 4 Returned to the company Director returned 452 shares (to the company)
  18. 4 Shares withheld for taxes Director gave up 4,524 shares (to pay taxes)
  19. 4 Option exercise Director acquired 1,401 shares (option exercise)
  20. 4 Option exercise Director acquired 1,401 shares (option exercise)

Page 4 of 18 · 345 filings